Skip to main content
Premium Trial:

Request an Annual Quote

Altos, Wasai Accelerated Genome Sequencing Solution

Acer subsidiary Altos Computing and WASAI Technology have globally launched an accelerated sequencing genome solution that will focus on human genome sequencing. The group said the development will integrate Altos' BrainSphere AI computing platform with WASAI's software to create a tool that is faster for genome sequencing without sacrificing accuracy. The joint solution will allow researchers to complete germline analyiss within eight hours. According to the firms, the tool will also help facilities accelerate native algorithms for resutls that are as precise and consistent as the original software. 

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.